{"filings":[{"id":649238,"accession_number":"0001849253-26-000031","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-05-26T11:15:13+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ryan Specialty boosts buyback authorization by $300M to $600M total","event_type":"other_material","confidence":"high","bullets":["Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.","Company repurchased $260M of Class A common stock in Q2 2026, exhausting prior $300M authorization.","After increase, $300M of authorization remains available as of May 22, 2026.","Founder and Executive Chairman Patrick G. Ryan cited Board's confidence in long-term strategy.","Repurchases may be made via open market, negotiated trades, or Rule 10b5-1 plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96204,"accession_number":"0001849253-26-000029","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ryan Specialty shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting","event_type":"other","confidence":"high","bullets":["All six director nominees elected; David P. Bolger received ~1.23B for, ~2.91M against.","Ratification of Deloitte & Touche as auditor for FY 2026 passed with ~1.25B for, ~106K against.","Advisory vote on executive compensation approved: ~1.24B for, ~203K against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96203,"accession_number":"0001849253-26-000023","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Ryan Specialty enters option settlement for up to $52.3M share repurchases","event_type":"other","confidence":"high","bullets":["Trust to sell up to ~$52.3M of Class A common stock to company at May 4 closing price.","Repurchases offset share issuance from employee stock options granted on May 5, 2026.","Options vest over 3 years starting July 2029, expire 2036; agreement runs through June 2036.","Purpose is to keep outstanding share count net neutral while incentivizing employees.","Repurchased shares will be cancelled and retired."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96202,"accession_number":"0001849253-26-000022","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss","event_type":"earnings","confidence":"high","bullets":["Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.","Net income $40.6M ($0.13 diluted EPS) vs $(4.4M) loss in prior-year; adjusted diluted EPS $0.47 (+20.5%).","Adjusted EBITDAC $232.0M (+15.7%); margin 29.2% vs 29.1% prior-year.","Board declared $0.13/share quarterly dividend, payable May 26 to holders of record May 12; repurchased $40M of stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":795229000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109896,"accession_number":"0001849253-26-000004","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["2.02","2.05","7.01","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q4 revenue +13% to $751M; net income down 27%; announces $300M buyback and restructuring","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.","Q4 net income $31.2M (-26.6%); GAAP EPS $0.06; adjusted EPS $0.45 (flat YoY).","Board approved three-year 'Empower Program' with ~$160M pre-tax charges, targeting $80M annual savings by 2029.","$300M share repurchase program authorized; quarterly dividend $0.13 payable March 10, 2026.","FY 2025 revenue $3.05B (+21.3%); adjusted EBITDAC $966.7M (+19.2%); adjusted EPS $1.96 (+9.5%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":3051126000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109895,"accession_number":"0001628280-26-007479","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Ryan Specialty sets 2026 annual meeting for April 28; record date March 2","event_type":"other","confidence":"high","bullets":["Annual meeting date: April 28, 2026; held virtually.","Record date for voting: March 2, 2026.","Rule 14a-8 proposals due by February 22, 2026.","Director nominations and other proposals due by February 20, 2026.","Company address for submissions: 155 N. Wacker Dr., Suite 4000, Chicago, IL."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126455,"accession_number":"0001849253-25-000018","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Board member Bobby Le Blanc to retire Feb. 11, 2026 after Onex sells stake","event_type":"leadership","confidence":"high","bullets":["Robert Le Blanc, Onex CEO, retires from Ryan Specialty Board effective February 11, 2026; mutual agreement.","Departure follows Onex's sale of its remaining shares in Ryan Specialty; no disagreement with the Company.","Le Blanc's tenure on Compensation and Governance Committee also ends on same date.","Company expresses gratitude for his service since 2018, originally as Onex nominee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126454,"accession_number":"0001849253-25-000013","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M","event_type":"earnings","confidence":"high","bullets":["Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).","Net income $62.6M, +118.6% YoY; adjusted diluted EPS $0.47, +14.6%.","Adjusted EBITDAC $235.5M, +23.8%; margin 31.2%.","Board declared $0.12/share quarterly dividend, payable Nov 25, 2025 to holders of record Nov 11.","Strong contribution from recent M&A; continued strategic investments in talent and technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2299913000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126453,"accession_number":"0001849253-25-000008","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor","event_type":"leadership","confidence":"high","bullets":["Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.","Appointments effective Oct 9, 2025; both report to CEO Tim Turner.","Jeremiah Bickham transitions from President to non-employee strategic advisor through Jan 1, 2026.","Bickham had been with Ryan Specialty for nearly 14 years; Keogh joined in May 2025.","Mulshine has been with the firm since 2012; both have over 30 years of insurance industry experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143200,"accession_number":"0001849253-25-000004","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ryan Specialty elects Michael G. Bungert to board; former Aon Re Chairman","event_type":"leadership","confidence":"high","bullets":["Michael G. Bungert joined board effective Sept 3, 2025; assigned to Compensation and Governance Committee.","Bungert retired as Chairman of Aon Re Global in 2024 after 11-year tenure; 40+ years in reinsurance.","Initial term expires at 2026 annual meeting; will receive $200k prorated RSU grant (vests immediately) and $120k annual cash retainer.","No related transactions or arrangements requiring disclosure under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143199,"accession_number":"0001628280-25-036997","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend","event_type":"earnings","confidence":"high","bullets":["Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.","Net income $124.7M (+5.6%); adjusted net income $184.7M (+15.0%); adjusted diluted EPS $0.66 (+13.8%).","Adjusted EBITDAC $308.4M (+24.5%); margin 36.1% expanded 50 bps YoY.","Board declared $0.12/share quarterly dividend, payable Aug 26 to holders of record Aug 12.","Completed three acquisitions in recent months to strengthen delegated authority capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1545336000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143198,"accession_number":"0001628280-25-035218","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ryan Specialty board lead director Cam Findlay dies; successors named","event_type":"leadership","confidence":"high","bullets":["D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.","Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chair of Compensation & Governance Committee.","Findlay previously served as GC at Archer Daniels Midland, Medtronic, and Aon, and in White House and Labor Dept. roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161332,"accession_number":"0001628280-25-029168","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["3.03","5.03","5.07","9.01"],"status":"ready","headline":"Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029","event_type":"other_material","confidence":"high","bullets":["Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.","Class B common stock's 10-to-1 voting disparity will sunset on September 30, 2029, equalizing voting power with Class A.","Stockholders granted rights to act by written consent and to call special meetings, enhancing shareholder democracy.","Supermajority voting requirements eliminated for director removal and charter/bylaw amendments; majority standard applies going forward.","Officer exculpation provision adopted to maximum extent under Delaware law, reducing personal liability risk for officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161331,"accession_number":"0001628280-25-021523","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend","event_type":"earnings","confidence":"high","bullets":["Total revenue $690.2M (+25% YoY); organic growth 12.9%.","GAAP net loss $(4.4)M vs $40.7M income in Q1 2024; diluted loss $(0.22) per share.","Adjusted EBITDAC $200.5M (+27.5%), margin 29.1%; adjusted diluted EPS $0.39 (+11.4%).","Quarterly dividend of $0.12 per share declared; payable May 27, 2025 to holders of record May 13, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":690166000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179492,"accession_number":"0001628280-25-015192","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ryan Specialty appoints Steve Keogh as COO effective May 1, 2025","event_type":"leadership","confidence":"high","bullets":["Keogh was Senior Advisor to Aon's Office of President and formerly President of Aon's Commercial Risk Solutions.","Base salary of $600,000; annual bonus target of 150% of base under Executive Incentive Corporate Plan.","Initial PSU grant of $2M vesting July 1, 2030 subject to organic revenue CAGR and stock price CAGR targets.","Keogh brings over 32 years of experience at Aon in operations, finance, tech, and executive management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179491,"accession_number":"0001628280-25-006736","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend","event_type":"earnings","confidence":"high","bullets":["Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).","Adjusted EBITDAC $216.0M (+36.2%); margin 32.6% vs 29.8%.","GAAP net income $42.6M (-27.3% YoY); adjusted diluted EPS $0.45 (+28.6%).","Board declared regular quarterly dividend $0.12/share, payable March 18, 2025 to holders of record March 4, 2025.","FY2024 revenue $2.5B (+21.1%); 7 acquisitions closed in 2024; recent acquisition of Velocity Risk Underwriters in Jan 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2515710000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}